185 related articles for article (PubMed ID: 3002267)
1. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
2. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
3. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity and molecular features of benzimidazoles.
O'Sullivan DG; Ludlow C; Pantic D; Wallis AK
Antimicrob Agents Chemother (Bethesda); 1969; 9():153-9. PubMed ID: 4319306
[No Abstract] [Full Text] [Related]
5. [Antiviral activity of imidazole derivatives. IV. Sensitivity of different viruses].
Tonew M; Tonew EM; Zöpel P
Arch Gesamte Virusforsch; 1971; 34(3):250-4. PubMed ID: 4330139
[No Abstract] [Full Text] [Related]
6. Inhibitors of picornavirus uncoating as antiviral agents.
Diana GD; Otto MJ; McKinlay MA
Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
[No Abstract] [Full Text] [Related]
7. Treatment of picornavirus infections.
Rotbart HA
Antiviral Res; 2002 Feb; 53(2):83-98. PubMed ID: 11750935
[TBL] [Abstract][Full Text] [Related]
8. Current status of anti-picornavirus therapies.
Barnard DL
Curr Pharm Des; 2006; 12(11):1379-90. PubMed ID: 16611122
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
Tonew M; Tonew E; Oehring H; Schmidt J
Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
[TBL] [Abstract][Full Text] [Related]
10. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
[TBL] [Abstract][Full Text] [Related]
11. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
Heinz BA; Vance LM
J Virol; 1996 Jul; 70(7):4854-7. PubMed ID: 8676522
[TBL] [Abstract][Full Text] [Related]
12. Antiviral properties of 1-allyl and 1-crotyl derivatives of 2-( -hydroxybenzyl) benzimidazole.
O'Sullivan DG; Ludlow CM
Experientia; 1972 Aug; 28(8):889-90. PubMed ID: 4342512
[No Abstract] [Full Text] [Related]
13. The in vitro antiviral activity of a triazinoindole (SK&F 40491).
Haff RF; Flagg WB; Gallo JJ; Hoover JR; Miller JA; Pinto CA; Pagano JF
Proc Soc Exp Biol Med; 1972 Nov; 141(2):475-8. PubMed ID: 4344266
[No Abstract] [Full Text] [Related]
14. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
Stone JK; Rijnbrand R; Stein DA; Ma Y; Yang Y; Iversen PL; Andino R
Antimicrob Agents Chemother; 2008 Jun; 52(6):1970-81. PubMed ID: 18347107
[TBL] [Abstract][Full Text] [Related]
15. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.
De Palma AM; Heggermont W; Leyssen P; Pürstinger G; Wimmer E; De Clercq E; Rao A; Monforte AM; Chimirri A; Neyts J
Biochem Biophys Res Commun; 2007 Feb; 353(3):628-32. PubMed ID: 17194441
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
[TBL] [Abstract][Full Text] [Related]
17. Further biochemical testing of feline picornaviruses.
Bürki F; Pichler L
Arch Gesamte Virusforsch; 1971; 33(1):126-33. PubMed ID: 4325970
[No Abstract] [Full Text] [Related]
18. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
19. Towards the design of combination therapy for the treatment of enterovirus infections.
Thibaut HJ; Leyssen P; Puerstinger G; Muigg A; Neyts J; De Palma AM
Antiviral Res; 2011 Jun; 90(3):213-7. PubMed ID: 21466823
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
